Rebecca Rodger

Clinical Strategy Manager – Advanced Wound Care
Specialist Wound Care and MSK Podiatrist

Rebecca Rodger is an experienced clinical strategist specializing in wound care and medical device innovation. At Convatec, she leads global clinical evidence initiatives for the Foam and Fibre portfolio, including the company’s first randomized controlled trial.

With a background in Podiatry and Medical Affairs, Rebecca brings deep expertise in clinical trial design, regulatory compliance, and post-market surveillance. She is a published author in peer-reviewed journals and a regular speaker at medical conferences, where she shares insights on evidence-based approaches to improving patient outcomes.

In her spare time, Rebecca still works clinically within her own Podiatry practice in Kendal, Cumbria.

Are all Antimicrobial Dressings the Same? Clinical Study Data on Two Novel Antibiofilm Dressing Technologies

Join Rebecca Rodger and Dr. Daniel Metcalf as they explore the science behind biofilm in hard-to-heal wounds and why not all antimicrobial dressings deliver the same outcomes.

This session will cover:

• • The role of biofilm in delayed healing and strategies for effective biofilm management.
  • Evidence from real-world practice and randomised controlled trials comparing standard of care to:
    • An antibiofilm silver Hydrofiber dressing.
    • A new nitric oxide-generating dressing for diabetic foot ulcers.
    • Practical insights on optimising silver dressing use, including the “two-week challenge”.

Delegates will leave with actionable knowledge to improve clinical decision-making and patient outcomes in foot and ankle wound care.